EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors of Long COVID in Adults With Untreated Mild-to-Moderate Coronavirus Disease 2019

Teresa H Evering iD, Pooja T Saha iD, Carlee Moser, Nikolaus Jilg iD, Rachel A Bender Ignacio iD, Prasanna Jagannathan iD, Katya Corado, Kevin Wongsodirdjo, Justin Ritz, Jonathan Z Li iD, Davey M Smith, Judith S Currier iD und 2 weitere

Open Forum Infectious Diseases · 31.10.2026 · 13 (11)

DOI: 10.1093/ofid/ofag577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 13.11.2026. Verfasst von Teresa H Evering und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medicine, New York, New York, USA. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We evaluated risk factors for long COVID (LC) in the ACTIV-2/A5401 trial, with a focus on understanding the impact of sex.

Methods

Findings were analyzed in nonhospitalized adults with coronavirus disease 2019 (COVID-19) receiving placebo within 10 days of symptoms. LC was defined as self-reporting COVID-19–related symptoms at study week 24 in a diary. Demographics and clinical variables, nasal viral RNA (vRNA), and inflammatory/coagulation markers were evaluated as predictors of LC, using modified Poisson regression models.

Results

Among 545 participants enrolled in January–August 2021 with a week 24 diary, the median age at entry was 44 years, 53% were female, 13% Black, 53% Hispanic/Latino, 83% US enrolled, 15% vaccinated, and 52% severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositive. Seventy-four (14%) had LC (19% of female and 7% of male participants). Female sex was strongly associated with LC (adjusted risk ratio, 2.64 [95% confidence interval, 1.58–4.42]). Other predictors included US enrollment, higher total symptom score at entry, presence of symptoms at the end of the acute period (days 22–28), 28-day area under the curve of vRNA levels, and higher day 28 C-reactive protein and fibrinogen. The effect of sex persisted with adjustment for the other variables, and associations with symptoms and fibrinogen level varied by sex.

Conclusions

In untreated adults with COVID-19, female sex, US enrollment, symptom and vRNA burden, and inflammatory/coagulation measures were associated with increased LC risk, with some associations varying by sex. The association with female sex was not significantly attenuated by adjustment for the assessed biomarkers. These data support sex-stratified investigations of LC, as well as a potential role of thromboinflammation. Clinical Trials Registration ClinicalTrials.gov NCT04518410.

Schlagwörter

Stichwörter der Autor:innen

clinical triallong COVIDpost-COVID conditionpostacute sequelae of SARS-CoV-2 infection (PASC)sex-stratification

Autor:innen und Institutionen

  • Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Department of Medicine, Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Teresa H Evering, Pooja T Saha, Nikolaus Jilg, Rachel A Bender Ignacio, Prasanna Jagannathan, Jonathan Z Li, Judith S Currier

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Evering, T. H., Saha, P. T., Moser, C., Jilg, N., Bender Ignacio, R. A., Jagannathan, P., Corado, K., Wongsodirdjo, K., Ritz, J., Li, J. Z., Smith, D. M., Currier, J. S., Hughes, M. D., & Chew, K. W. (2026). Predictors of Long COVID in Adults With Untreated Mild-to-Moderate Coronavirus Disease 2019. Open Forum Infectious Diseases, 13(11). https://doi.org/10.1093/ofid/ofag577

Vancouver

Evering TH, Saha PT, Moser C, Jilg N, Bender Ignacio RA, Jagannathan P, et al. Predictors of Long COVID in Adults With Untreated Mild-to-Moderate Coronavirus Disease 2019. Open Forum Infectious Diseases. 2026;13(11). doi:10.1093/ofid/ofag577

BibTeX
@article{Evering2026,
  author = {Evering, Teresa H and Saha, Pooja T and Moser, Carlee and Jilg, Nikolaus and Bender Ignacio, Rachel A and Jagannathan, Prasanna and Corado, Katya and Wongsodirdjo, Kevin and Ritz, Justin and Li, Jonathan Z and Smith, Davey M and Currier, Judith S and Hughes, Michael D and Chew, Kara W},
  title = {Predictors of Long COVID in Adults With Untreated Mild-to-Moderate Coronavirus Disease 2019},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {11},
  doi = {10.1093/ofid/ofag577}
}
Kostenlos starten →